pyruvaldehyde has been researched along with concanavalin a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, LG; Kang, Y; Thornalley, PJ | 1 |
| Abordo, EA; Limb, GA; Thornalley, PJ; Webster, L | 1 |
| Bhattacharyya, N; Haldar, AK; Pal, A; Patra, S; Ray, M; Roy, S | 1 |
3 other study(ies) available for pyruvaldehyde and concanavalin a
| Article | Year |
|---|---|
Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA G1 growth arrest and induction of apoptosis.
Topics: Apoptosis; Cell Cycle; Cell Division; Concanavalin A; DNA, Neoplasm; G1 Phase; Glyceraldehyde-3-Phosphate Dehydrogenases; HL-60 Cells; Humans; Lymphocyte Activation; Lymphocytes; Neoplasm Proteins; Pyruvaldehyde; RNA, Neoplasm; Stimulation, Chemical | 1996 |
Induction of TNF alpha and IL-1 beta mRNA in monocytes by methylglyoxal- and advanced glycated endproduct-modified human serum albumin.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Concanavalin A; Glycation End Products, Advanced; Humans; In Vitro Techniques; Interleukin-1; Monocytes; Pyruvaldehyde; RNA, Messenger; Serum Albumin; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1997 |
Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Concanavalin A; Cytotoxicity, Immunologic; Female; Interferon-gamma; Interleukin-12; Lymphocyte Activation; Lymphocytes; Macrophage Activation; Macrophages, Peritoneal; Mice; NADP; Nitric Oxide Synthase Type II; Nitrites; Pyruvaldehyde; Sarcoma 180; Superoxides; Tumor Necrosis Factor-alpha | 2008 |